Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Graft vs Host Disease | Phase 2/Phase 3 | ClinicalTrials |
| Alpha 1-Antitrypsin Deficiency; Emphysema; Pulmonary Emphysema | Phase 2 | ClinicalTrials |
| Pancreatitis; Pancreatitis, Chronic | Phase 1/Phase 2 | ClinicalTrials |
| Alpha 1-Antitrypsin Deficiency | Phase 3 | ClinicalTrials |
| Alpha 1-Antitrypsin Deficiency | Phase 3 | ClinicalTrials |
| Alpha 1-Antitrypsin Deficiency | Phase 2 | ClinicalTrials |
| Alpha 1-Antitrypsin Deficiency; Emphysema; Pulmonary Emphysema | Phase 4 | ClinicalTrials |
| Pancreatitis; Pancreatitis, Chronic | Phase 4 | ClinicalTrials |
| Infarction; Myocardial Infarction | Phase 1/Phase 2 | ClinicalTrials |
| Cystic Fibrosis; Fibrosis | Phase 2 | ClinicalTrials |
| Alpha 1-Antitrypsin Deficiency | Phase 4 | ClinicalTrials |
| Alpha 1-Antitrypsin Deficiency | Phase 3 | ClinicalTrials |
| Diabetes Mellitus, Type 1 | Phase 2 | ClinicalTrials |
| Graft vs Host Disease | Phase 2 | ClinicalTrials |
| Alpha 1-Antitrypsin Deficiency | Phase 2/Phase 3 | ClinicalTrials |
| Alpha 1-Antitrypsin Deficiency | Phase 4 | ClinicalTrials |
CONTENTS